雌激素上调DNMT1并导致RUNX3高甲基化在卵巢子宫内膜异位症恶变中的作用
该研究探讨子宫内膜异位症在位内膜中RUNX3高甲基化作为恶变生物标志物的机制。采用甲基化特异性PCR分析RUNX3甲基化状态,并分离在位内膜基质细胞进行功能实验。结果发现RUNX3在恶变组织中甲基化频率显著高于内异症组,雌激素可上调DNMT1并诱导RUNX3高甲基化,提示「雌激素-DNMT1」信号通路可能参与恶变过程。
要点
- RUNX3在子宫内膜异位症相关卵巢癌肿瘤组织中的甲基化频率显著高于内异症组异位内膜(P < 0.001)。
- 雌激素干预后,雌二醇组RUNX3甲基化水平及DNMT1 mRNA和蛋白表达均高于ESC组(P < 0.001)。
- 沉默RUNX3可促进子宫内膜异位症在位内膜基质细胞的增殖和侵袭(P < 0.001)。
核心结论
- RUNX3高甲基化与子宫内膜异位症恶变相关,且该过程与在位内膜的相应改变有关。
- 「雌激素-DNMT1」信号通路可能诱导RUNX3高甲基化,从而促进子宫内膜异位症恶变。
研究设计与样本
- 采用甲基化特异性聚合酶链反应分析子宫内膜异位症相关卵巢癌中RUNX3的甲基化状态。
- 从卵巢子宫内膜异位症患者子宫分离原代在位内膜基质细胞(ESC),经RNA干扰技术敲低RUNX3或用雌二醇处理ESC后,采用MTT法和Transwell实验评估ESC的增殖和侵袭能力。
主要发现
- 子宫内膜异位症相关卵巢癌组肿瘤组织中RUNX3甲基化频率显著高于子宫内膜异位症组异位内膜(P < 0.001)。
- 子宫内膜异位症相关卵巢癌组在位内膜中RUNX3甲基化频率显著高于子宫内膜异位症组(P < 0.001)。
- 子宫内膜异位症组在位内膜与对照组在位内膜比较,RUNX3甲基化频率无显著差异(P = 0.233)。
- 沉默RUNX3可促进ESC的增殖和侵袭(P < 0.001和P < 0.001)。
- 雌二醇组RUNX3甲基化水平及DNMT1 mRNA和蛋白表达均高于ESC组(P < 0.001和P < 0.001),RUNX3 mRNA和蛋白表达低于ESC组(P < 0.001和P < 0.001)。
关键数值与推荐
- 子宫内膜异位症相关卵巢癌组肿瘤组织RUNX3甲基化频率显著高于子宫内膜异位症组异位内膜(P < 0.001)。
- 子宫内膜异位症相关卵巢癌组在位内膜RUNX3甲基化频率显著高于子宫内膜异位症组(P < 0.001)。
- 子宫内膜异位症组与对照组在位内膜RUNX3甲基化频率无显著差异(P = 0.233)。
- 雌二醇组RUNX3甲基化水平高于ESC组(P < 0.001),DNMT1 mRNA和蛋白表达高于ESC组(P < 0.001和P < 0.001),RUNX3 mRNA和蛋白表达低于ESC组(P < 0.001和P < 0.001)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the mechanism of hypermethylation of runt-related transcription factor 3 (RUNX3) in the eutopic endometrium of endometriosis as biomarker in the malignant transformation of endometriosis? DESIGN: Methylation-specific polymerase chain reaction was used to analyse the methylation status of RUNX3 in endometriosis-associated ovarian cancer (EAOC). Primary eutopic endometrial stromal cells (ESC) were isolated from the uteri of patients with ovarian endometriosis. After RUNX3 knockdown by RNA interference technology or ESC treated with oestradiol, the proliferation and invasion ability were evaluated in ESC by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and transwell assays. RESULTS: The frequency of methylation of RUNX3 in neoplastic tissue in the EAOC group was significantly higher than that in the ectopic endometrium of the endometriosis group (P < 0.001), and the frequency of methylation of RUNX3 in the eutopic endometrium of the EAOC group was significantly higher than that in the endometriosis group (P < 0.001). However, there was no significant difference in the eutopic endometrium when compared between the endometriosis group and the control endometrium group (P = 0.233). Silencing RUNX3 promoted the proliferation and invasion of ESC (P < 0.001 and P < 0.001). Following intervention with oestrogen, it was observed that the oestradiol group showed higher levels of RUNX3 methylation (P < 0.001) and DNA methyltransferase 1 (DNMT1) mRNA and protein expression (P < 0.001 and P < 0.001), and lower RUNX3 mRNA and protein expression when compared with the ESC group (P < 0.001 and P < 0.001). CONCLUSION: This study demonstrated that hypermethylation of the RUNX3 was related to the malignant transformation of endometriosis and that this process was related to corresponding changes in the eutopic endometrium. Furthermore, the 'oestrogen-DNMT1' signalling pathway may induce the hypermethylation of RUNX3 to promote the malignant transformation of endometriosis.
引用
- Wang D, Guo C, Li Y, et al. Oestrogen up-regulates DNMT1 and leads to the hypermethylation of RUNX3 in the malignant transformation of ovarian endometriosis. Reprod Biomed Online. 2021. PMID: 34799276. doi:10.1016/j.rbmo.2021.06.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。